Dr. Walid Mangal, DO

Dr. Mangal practices at Brain and Spine Neurosugery,LLC in Stuart, Florida.

Dr. Mangal's NPI, 1659529055, was assigned on August 28, 2008. Dr. Mangal graduated from Pcom in 2008. Dr. Mangal holds Florida license OS12479.

Dr. Mangal's primary practice is Brain and Spine Neurosugery,LLC, at 1050 SE Monterey Rd, Stuart, FL 34994 in Martin County. The practice phone is (772) 220-9700.

Dr. Mangal's primary practice is Brain and Spine Neurosugery,LLC in Stuart, Florida. Dmand AI also links Dr. Mangal to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mangal practices. Vendor and product names are available with a free account.

Retina specialist is Dr. Mangal's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Mangal is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Mangal's licenses on file in 3 states: Florida, Maryland and Virginia.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, dry eye, eye infection or inflammation, glaucoma, hereditary corneal conditions and hypertensive retinopathy among the conditions Dr. Mangal treats.

CMS data shows 45,120 Medicare services from Dr. Mangal across 23 procedure codes in 2024, for 1,632 Medicare patients. Medicare paid $2,434,623 for them. Every service was in an office.

CMS counts 1,632 Medicare patients who saw Dr. Mangal in 2024. The largest group is 65 to 74, with 694 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mangal's median patient age at 73, with 56% women.

In 2024, Dr. Mangal wrote 1,570 Medicare Part D claims for 401 patients. 14% of them were for generic drugs. CMS names the drug for 1,523 of them, across 14 drugs with 11 or more claims each, at $2,912,905 in total drug cost. In 2023, CMS named 1,609 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Mangal for performance year 2024, reported individually. Dr. Mangal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Mangal.

CMS Open Payments shows 132 general payments to Dr. Mangal from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 50% of the total. Carl Zeiss Meditec, Inc. paid the most, $3,935.

Dr. Mangal graduated from Pcom in 2008.

Dr. Mangal is in network with 11 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.